Evidence for a genetic basis of urogenital carcinoma in the wild California sea lion

Proceedings of the Royal Society B: Biological Sciences

Volumn 281, Issue 1796, 2014, Pages

  Browning, Helen M ^a   Acevedo Whitehouse, Karina ^b   Gulland, Frances M D ^c   Hall, Ailsa J ^a   Finlayson, Jeanie ^d   Dagleish, Mark P ^d   Billington, Karen J ^e   Colegrove, Kathleen ^f   Hammond, John A ^e  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSIDAD AUTÓNOMA DE QUERÉTARO   (Mexico)

^c THE MARINE MAMMAL CENTER   (United States)

^d MOREDUN RESEARCH INSTITUTE   (United Kingdom)

^e INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Cancer; Heparanase 2 gene; Odds ratio; Wildlife

Indexed keywords

CANCER; DOMESTIC SPECIES; ETIOLOGY; GENE EXPRESSION; GENETIC MARKER; GENOTYPE; INBREEDING DEPRESSION; MORTALITY; PINNIPED; REPRODUCTIVE DISORDER; WILD POPULATION;

ZALOPHUS;

BETA GLUCURONIDASE; MICROSATELLITE DNA;

ANIMAL; CARCINOMA; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HETEROZYGOSITY LOSS; INBREEDING; ODDS RATIO; OTARIIDAE; UROGENITAL TRACT TUMOR; VETERINARY;

ANIMALS; CARCINOMA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCURONIDASE; INBREEDING; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; ODDS RATIO; SEA LIONS; UROGENITAL NEOPLASMS;

EID: 84908141398     PISSN: 09628452     EISSN: 14712954     Source Type: Journal    
DOI: 10.1098/rspb.2014.0240     Document Type: Article

References (41)

1. Hawkins CE et al. 2006 Emerging disease and population decline of an island endemic, the Tasmanian devil Sarcophilus harrisii. Biol. Conserv. 131, 307-324. (doi:10.1016/j.biocon.2006.04.010)
2. Woolford L et al. 2008 Cutaneous papillomatosis and carcinomatosis in the Western barred bandicoot (Perameles bougainville). Vet. Pathol. 45, 95-103. (doi:10.1354/vp.45-1-95)
3. Greenblatt RJ, Quackenbush SL, Casey RN, Rovnak J, Balazs GH, Work TM, Casey JW, Sutton CA. 2005 Genomic variation of the fibropapilloma-associated marine turtle herpesvirus across seven geographic areas and three host species. J. Virol. 79, 1125- 1132. (doi:10.1128/JVI.79.2.1125-1132.2005)
4. McAloose D, Newton AL. 2009 Wildlife cancer: a conservation perspective. Nat. Rev. Cancer 9, 517-526. (doi:10.1038/nrc2665)
5. De Guise S, Lagace A, Beland P. 1994 Tumors in St Lawrence beluga whales (Delphinapterus leucas). Vet. Pathol. 31, 444-449. (doi:10.1177/ 030098589403100406)
6. Gulland FM, Trupkiewicz JG, Spraker TR, Lowenstine LJ. 1996 Metastatic carcinoma of probable transitional cell origin in 66 free-living California sea lions (Zalophus californianus), 1979 to 1994. J. Wildl. Dis. 32, 250-258. (doi:10.7589/0090- 3558-32.2.250)
7. Buckles EL et al. 2006 Otarine herpesvirus-1, not papillomavirus, is associated with endemic tumours in California sea lions (Zalophus californianus). J. Comp. Pathol. 135, 183-189. (doi:10.1016/j.jcpa. 2006.06.007)
8. Johnson S, Lowenstine L, Gulland F, Jang S, Imai D, Almy F, Delong R, Gardner I. 2006 Aerobic bacterial flora of the vagina and prepuce of California sea lions (Zalophus californianus) and investigation of associations with urogenital carcinoma. Vet. Microbiol. 114, 94-103. (doi:10.1016/j.vetmic. 2005.11.045)
9. Ylitalo GM et al. 2005 The role of organochlorines in cancer-associated mortality in California sea lions (Zalophus californianus). Mar. Pollut. Bull. 50, 30-39. (doi:10.1016/j.marpolbul.2004.08.005)
10. Colegrove KM, Gulland FM, Naydan DK, Lowenstine LJ. 2009 Tumor morphology and immunohistochemical expression of estrogen receptor, progesterone receptor, p53, and Ki67 in urogenital carcinomas of California sea lions (Zalophus californianus). Vet. Pathol. 46, 642-655. (doi:10.1354/vp.08-VP-0214-C-FL)
11. Bowen L, Aldridge BM, Delong R, Melin S, Buckles EL, Gulland F, Lowenstine LJ, Stott JL, Johnson ML. 2005 An immunogenetic basis for the high prevalence of urogenital cancer in a free-ranging population of California sea lions (Zalophus californianus). Immunogenetics 56, 846-848. (doi:10.1007/s00251-004-0757-z)
12. Acevedo-Whitehouse K, Gulland F, Greig D, Amos W. 2003 Inbreeding: disease susceptibility in California sea lions. Nature 422, 35. (doi:10.1038/422035a)
13. Balloux F, Amos W, Coulson T. 2004 Does heterozygosity estimate inbreeding in real populations? Mol. Ecol. 13, 3021-3031. (doi:10. 1111/j.1365-294X.2004.02318.x)
14. Schusterman RJ, Dawson RG. 1968 Barking, dominance, and territoriality in male sea lions. Science 160, 434-436. (doi:10.1126/science.160. 3826.434)
15. Goodman SJ. 1997 Dinucleotide repeat polymorphisms at seven anonymous microsatellite loci cloned from the European harbour seal (Phoca vitulina vitulina). Anim. Genet. 28, 310-311.
16. Gemmell NJ, Allen PJ, Goodman SJ, Reed JZ. 1997 Interspecific microsatellite markers for the study of pinniped populations. Mol. Ecol. 6, 661-666. (doi:10.1046/j.1365-294X.1997.00235.x)
17. Worthington Wilmer J, Allen PJ, Pomeroy PP, Twiss SD, Amos W. 1999 Where have all the fathers gone? An extensive microsatellite analysis of paternity in the grey seal (Halichoerus grypus). Mol. Ecol. 8, 1417-1429. (doi:10.1046/j.1365-294x.1999.00705.x)
18. Hoffman JI, Matson CW, Amos W, Loughlin TR, Bickham JW. 2006 Deep genetic subdivision within a continuously distributed and highly vagile marine mammal, the Steller's sea lion (Eumetopias jubatus). Mol. Ecol. 15, 2821-2832. (doi:10.1111/j. 1365-294X.2006.02991.x)
19. Gulcher J. 2012 Microsatellite markers for linkage and association studies. Cold Spring Harb. Protoc. 2012, 425-432. (doi:10.1101/pdb.top068510)
20. Reynisdottir I et al. 2003 Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am. J. Hum. Genet. 73, 323-335. (doi:10.1086/377139)
21. Xu P et al. 2013 The (TTTA)n polymorphism in intron 4 of CYP19 and the polycystic ovary syndrome risk in a Chinese population. Mol. Biol. Rep. 40, 5041-5047. (doi:10.1007/s11033-013- 2605-4)
22. Stewart DR et al. 2006 Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity. J. Clin. Endocrinol. Metab. 91, 4112-4117. (doi:10.1210/jc.2006-0951)
23. Urbanek M, Sam S, Legro RS, Dunaif A. 2007 Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J. Clin. Endocrinol. Metab. 92, 4191-4198. (doi:10.1210/jc.2007-0761)
24. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, Sasaki H. 2000 Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am. J. Hum. Genet. 66, 187-195. (doi:10.1086/302729)
25. Bhattacharya TK, Rani S, Maiti SK, Dayal S, Kumar P, Sharma A. 2007 Polymorphism of ZuBeCa3 microsatellite and its association with mammary tumor in dogs. Int. J. Immunogenet. 34, 161-165. (doi:10.1111/j.1744-313X.2007.00639.x)
26. R Core Development Team. 2011 R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
27. Poetsch M, Petersmann A, Woenckhaus C, Protzel C, Dittberner T, Lignitz E, Kleist B. 2004 Evaluation of allelic alterations in short tandem repeats in different kinds of solid tumors-possible pitfalls in forensic casework. Forensic Sci. Int. 145, 1-6. (doi:10.1016/j.forsciint.2004.03.006)
28. Arnason U, Gullberg A, Janke A, Kullberg M, Lehman N, Petrov EA, Vainola R. 2006 Pinniped phylogeny and a new hypothesis for their origin and dispersal. Mol. Phylogenet. Evol. 41, 345-354. (doi:10.1016/j.ympev.2006.05.022)
29. McKenzie E et al. 2000 Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem. Biophys. Res. Commun. 276, 1170-1177. (doi:10.1006/bbrc.2000.3586)
30. Osborne AJ, Brauning R, Schultz JK, Kennedy MA, Slate J, Gemmell NJ. 2011 Development of a predicted physical map of microsatellite locus positions for pinnipeds, with wider applicability to the Carnivora. Mol. Ecol. Resour. 11, 503-513. (doi:10.1111/j.17550998.2010.02962.x)
31. Keller LF, Waller DM. 2002 Inbreeding effects in wild populations. Trends Ecol. Evol. 17, 230-241. (doi:10.1016/S0169-5347(02)02489-8)
32. Hansson B, Westerdahl H, Hasselquist D, Akesson M, Bensch S. 2004 Does linkage disequilibrium generate heterozygosity-fitness correlations in great reed warblers? Evolution 58, 870-879. (doi:10.1111/j.0014-3820.2004.tb00418.x)
33. Barash U, Cohen-Kaplan V, Dowek I, Sanderson RD, Ilan N, Vlodavsky I. 2010 Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis. FEBS J. 277, 3890-3903. (doi:10.1111/j.1742-4658.2010.07799.x)
34. Levy-Adam F et al. 2010 Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity. J. Biol. Chem. 285, 28 010- 28 019. (doi:10.1074/jbc.M110.116384)
35. de Moura Jr JP, Nicolau SM, Stavale JN, da Silva Pinhal MA, de Matos LL, Baracat EC, de Lima GR. 2009 Heparanase-2 expression in normal ovarian epithelium and in benign and malignant ovarian tumors. Int. J. Gynecol. Cancer 19, 1494-1500. (doi:10.1111/IGC.0b013e3181a834a2)
36. Peretti T et al. 2008 Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma. Eur. J. Gastroenterol. Hepatol. 20, 756-765. (doi:10.1097/MEG.0b013e3282fc2649)
37. Zhang X, Xu S, Tan Q, Liu L. 2013 High expression of heparanase-2 is an independent prognostic parameter for favorable survival in gastric cancer patients. Cancer Epidemiol. 37, 1010-1013. (doi:10. 1016/j.canep.2013.09.012)
38. Carracedo A, Alimonti A, Pandolfi PP. 2011 PTEN level in tumor suppression: how much is too little? Cancer Res. 71, 629-633. (doi:10.1158/0008-5472. CAN-10-24880008-5472)
39. Thiagalingam S, Foy RL, Cheng KH, Lee HJ, Thiagalingam A, Ponte JF. 2002 Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Curr. Opin. Oncol. 14, 65-72. (doi:10. 1097/00001622-200201000-00012)
40. Theodoro TR, de Matos LL, Sant Anna AV, Fonseca FL, Semedo P, Martins LC, Nader HB, Del Giglio A, da Silva Pinhal MA. 2007 Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/ or systemic metastasis. Neoplasia 9, 504-510. (doi:10.1593/neo.07241)
41. Stuart HM et al. 2013 LRIG2 mutations cause urofacial syndrome. Am. J. Hum. Genet. 92, 259-264. (doi:10.1016/j.ajhg.2012.12.002)